Variant Pathogenicity Predictorv1.0.0

Clinical labs use this skill to automatically classify variants from patient sequencing data, integrating multiple prediction scores to produce ACMG-compliant reports for hereditary disease testing.

Pharmaceutical companies evaluate variants in drug target genes to predict potential loss-of-function liabilities, using combined pathogenicity scores to prioritize safer targets during early drug discovery.

Public health initiatives screen large genomic datasets for pathogenic variants in actionable genes, applying this skill to filter and classify variants for carrier screening or newborn screening workflows.

Academic researchers studying rare diseases use the skill to prioritize candidate variants from family sequencing data, leveraging integrated scores to identify likely causative mutations for further functional studies.

Bioinformatics platform providers embed this skill into automated variant interpretation pipelines, offering clinicians a consistent, multi-score pathogenicity prediction along with confidence metrics.

Embed the predictor into a cloud-based genomic analysis platform, charging per variant query or monthly subscription fee for clinical labs and research institutions.

Offer as an optional add-on to existing genetic testing services, generating revenue per report or per-sample analysis fee for diagnostic laboratories.

Provide expert variant interpretation services using this tool, billing by project or hourly for biotech companies and research institutes lacking in-house capabilities.